The role of cyclins and cyclin dependent kinases in development and progression of hepatitis C virus-genotype 4-associated hepatitis and hepatocellular carcinoma

Experimental and Molecular Pathology

Volumn 91, Issue 2, 2011, Pages 643-652

  Bahnassy, Abeer A ^a   Zekri, Abdel Rahman N ^b   Loutfy, Samah A ^b   Mohamed, Waleed S ^b   Moneim, Amrallah Abdel ^c   Salem, Salem E ^b   Sheta, Marwa M ^d   Omar, Ashraf ^d   Al Zawahry, Heba ^b  

^a NATIONAL CANCER INSTITUTE   (Egypt)

^b CAIRO UNIVERSITY   (Egypt)

^c ZAGAZIG UNIVERSITY   (Egypt)

^d CAIRO UNIVERSITY   (Egypt)

Author keywords

Chronic hepatitis; Cyclin dependent kinases; Cyclins; Hepatocellular carcinoma; Prognosis

Indexed keywords

CYCLIN A; CYCLIN D1; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN E; CYCLINE; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER STAGING; CANCER SURVIVAL; CARCINOMATOSIS; CELL CYCLE REGULATION; CELL CYCLE S PHASE; CELL FRACTIONATION; CONTROLLED STUDY; CYCLIN A GENE; CYCLIN D1 GENE; CYCLIN DEPENDENT KINASE 2 GENE; CYCLIN DEPENDENT KINASE 4 GENE; CYCLIN E GENE; DISEASE ASSOCIATION; ENZYME ACTIVITY; FEMALE; FLOW CYTOMETRY; GENE FUNCTION; GENE OVEREXPRESSION; GENETIC ASSOCIATION; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; LIVER FIBROSIS; MALE; METASTASIS; OVERALL SURVIVAL; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATOR GENE; SURVIVAL TIME;

ADULT; AGED; BIOLOGICAL MARKERS; CARCINOMA, HEPATOCELLULAR; CYCLIN-DEPENDENT KINASES; CYCLINS; DISEASE PROGRESSION; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS, CHRONIC; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; MALE; MIDDLE AGED; S PHASE;

HEPATITIS C VIRUS; HEPATITIS C VIRUS GENOTYPE 4;

EID: 80053448451     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2011.06.014     Document Type: Article

References (39)

1. Agami R., Bernards R. Distinct initiation and maintenance mechanisms cooperate to induce G1 cell cycle arrest in response to DNA damage. Cell 2000, 102:55-66.
2. Alao J.P., Gamble S.C., Stavropoulou A.V., Pomeranz K.M., Lam E.W.-F., Coombes R.C., Vigushin D.M. The cyclin D1 proto-oncogene is sequestered in the cytoplasm of mammalian cancer cell lines. Mol. Cancer 2006, 5:7-18.
3. Albrecht J.H., Hu M.Y., Cerra F.B. Distinct patterns of cyclin D1 regulation in models of liver regeneration and human liver. Biochem. Biophys. Res. Commun. 1995, 209:648-655.
4. Anzola M. Hepatocellular carcinoma: role of hepatitis B and hepatitis C viruses proteins in hepatocarcinogenesis. J. Viral. Hepatol. 2004, 11(5):383-393.
5. Bahnassy A.A., Zekri A.R., El-Houssini S., El-Shehaby A.M., Mahmoud M.R., Abdallah S., El-Serafi M. Cyclin A and cyclin D1 as significant prognostic markers in colorectal cancer patients. BMC Gastroenterol. 2004, 23:4-22.
6. Bahnassy A.A., Zekri A.R., Alam El Din H.M., Aboubakr A.A., Kamel K., Elsabah M.T., Mokhtar N.M. The role of cyclins and cyclin inhibitors in the multistep process of HPV-associated cervical carcinoma. J. Nat. Can. Inst. 2006, 18:292-301.
7. Boom R., Sol C.J., Heijtink R., Wertheim-Van Dillen P.M., Van der Noordaa J. Rapid purification of hepatitis B virus DNA from serum. J. Clin. Microbiol. 1991, 29:1804-1811.
8. Callea F., Brisigotti M., Fabbretti G., Sciot R., Van Eyken P., Favret M. Cirrhosis of the liver. A regenerative process. Dig. Dis. Sci. 1991, 36(9):1287-1293.
9. Calvisi D.F., Ladu S., Gorden A., Farina M., Lee J.S., Conner E.A., Schroeder I., Factor V.M., Thorgeirsson S.S. Mechanistic and prognostic significance of aberrant methylation in the molecular pathogenesis of human hepatocellular carcinoma. J. Clin. Invest. 2007, 117(9):2713-2722.
10. Chao Y., Shih Y.L., Chiu J.H., Chau G.Y., Lui W.Y., Yang W.K., Lee S.D., et al. Overexpression of cyclin A but not Skp2 correlates with the tumor relapse of human hepatocellular carcinoma. Cancer Res. 1998, 58:985-990.
11. Chao Y., Shih Y.L., Chiu J.H., Chau G.Y., Lui W.Y., Yang W.K., Lee S.D., et al. Overexpression of cyclin A but not Skp2 correlates with the tumor relapse of human hepatocellular carcinoma. Cancer Res. 1998, 58:985-990.
12. Corrover S., Maitre B., Cazals V., Clement A. Altered regulation of G1 cyclins in oxidant-induced growth arrest of lung alveolar epithelial cells. Accumulation of inactive cyclin E-DCK2 complexes. J. Biol. Chem. 1996, 271(41):25117-25125.
13. Delhaye M., Louis H., Degraef C., Le Moine O., Deviere J., Peny M.O., Adler M., Galand P. Hepatocyte proliferative activity in human liver cirrhosis. J. Hepatol. 1999, 30(3):461-471.
14. Diehl J.A., Cheng M., Roussel M.F., Sherr C.J. Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization. Genes Dev. 1998, 12:3499-3511.
15. El Bassiouny A.E., Nosseir M.M., Zoheiry M.K., Ameen N.A., Andel-Hadi A.M., Ibrahim I.M., Zada S., Saad El-Deen A., Bassiouni N.E. Differential expression in cell cycle regulators in HCV-infection and related hepatocellular carcinoma. World J. Hepatol. 2010, 27; 2(1):32-41.
16. Germain D., Russell A., Thompson A., Hendley J. Ubiquitination of free cyclin D1 is independent of phosphorylation on threonine 286. J. Biol. Chem. 2000, 275:12074-12079.
17. Hamilton S.R., Aaltonen L.A. World Health Organization classification of tumors. Pathology and Genetics of Tumors of Digestive System 2000, 157-202. IARC Press, Lyon.
18. Helin K. Regulation of cell proliferation by the E2F transcription factors. Curr. Opin. Genet. Dev. 1998, 8:28-35.
19. Ishak K., Baptista A., Bianchi L., Callea F., Degroote J., Denk F. Histopathological staging and grading of chronic hepatitis. J. Hepatol. 1995, 22:696-699.
20. Ito Y., Sasaki Y., Horimoto M., Wada S., Tanaka Y., Kasahara A., Ueki T., et al. Activation of mitogen-activated protein kinase extracellular signal regulated kinases in human hepatocellular carcinoma. Hepatology 1998, 4:951-958.
21. Jung Y.J., Lee K.H., Choi D.W., Han C.J., Jeong S.H., Kim K.C., Oh J.W., Park T.K., Kim C.M. Reciprocal expressions of cyclin E and cyclin D1 in hepatocellular carcinoma. Cancer Lett. 2001, 168:57-63.
22. Lukas J., Pagano M., Staskova Z., Draetta G., Bartek J. Cyclin D1 protein oscillates and is essential for cell cycle progression in human tumor cell line. Oncogene 1994, 707-718.
23. Masaki T., Shiratori Y., Rengifo W., Igarashi K., Yamagata M., Kurokohchi K. Cyclins and cyclin-dependent kinases: comparative study of hepatocellular carcinoma versus cirrhosis. Hepatology 2003, 37(3):534-543.
24. Mokhtar N., Gouda I., Adel I. Cancer Pathology Registry 2003-2004 and Time Trend Analysis 2007, 12-15.
25. Nishida N., Fukuda Y., Komeda T., Kita R., Sando T., Furukawa M. Amplification and overexpression of the cyclin D1 gene in aggressive human hepatocellular carcinoma. Cancer Res. 1994, 54:3107-3110.
26. Okuda K. Hepatocellular carcinoma. J. Hepatol. 2000, 32(1 Suppl):225-237.
27. Peng S.-Y., C S-P., H H-C. Association of downregulation of cyclin D1 and of overexpression of cyclin E with p53 mutation, high tumor grade and poor prognosis in hepatocellular carcinoma. Journal of Hepatology 1998, 29:281-289.
28. Pinto A.E., Silva G., Banito A., Leite V., Soares J. Aneuploidy and high S-phase as biomarkers of poor clinical outcome in poorly differentiated and anaplastic thyroid carcinoma. Oncol. Rep. 2008, 20(4):913-919.
29. Safraz S., Hamid S., Siddiqui A., Hussain S., Pervez S., Alexander G. Altered expression of cell cycle and apoptotic proteins in chronic hepatitis C virus infection. BMC Microbiol. 2008, 8:133.
30. Street A., Macdonald A., McCormicK C., Harris M. Hepatitis C virus NS5A-mediated activation of phosphoinositide 3-kinase results in stabilization of cellular ß-catenin and stimulation of ß-catenin-responsive transcription. J. Virol. 2005, 79(8):5006-5016.
31. Tannapfel A., Anhalt K., Hausermann P., Sommerer F., Benicke M., Uhlmann D., Witzigmann H., Hauss J., Wittekind C. Identification of novel proteins associated with hepatocellular carcinomas using protein microarrays. J. Pathol. 2003, 201(2):238-249.
32. Taya Y. Cell cycle-dependent phosphorylation of the tumor suppressor RB protein. Mol. Cells 1995, 5:191-195.
33. Wright T.C., Denny L., Kuhn L., Pollack A., Lorincz A. HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer. JAMA 2000, 283:81-86.
34. Yamagata M., Masaki T., Okudaira T., Imai Y., Shina S., Shiratori Y., Omata M. Small hyperechoic nodules in chronic liver diseases include hepatocellular carcinoma with low cyclin D1 and Ki-67 expression. Hepatology 1999, 6:1722-1729.
35. Zekri A.R., Bahnassy A.A., Madbouly M.S., Asaad N.Y., El-Shehaby A.M., Alam El Din H.M. Mutation in HCV-genotype-4 associated hepatocellular carcinoma in Egyptian patients. J. Egypt Natl. Cancer Inst. 2006, 18(1):17-29.
36. Zekri A.R., Hafez M.M., Bahnassy A.A., Hassan Z.K., Mansour T., Kamal M.M., Khaled H.M. Genetic profile of Egyptian hepatocellular-carcinoma associated with hepatitis C virus Genotype 4 by 15 K cDNA microarray: preliminary study. BMC Res. Notes 2008, 29(1):106.
37. Zekri A.-R., Bahnassy A., Abdel-Wahab S., Khafagy M., Loutfy S., Radwan H., Shaarawy S. Expression of pro- and anti-inflammatory cytokines in relation to apoptotic genes in Egyptian liver disease patients associated with HCV-genotype 4. J. Gastroenterol. Hepatol. 2009, 24:416-428.
38. Zhang Y.J., Jiang W., Chen C.J., Lee C.S., Kahn S.M., Santella R.M. Amplification and overexpression of cyclin D1 in human hepatocellular carcinoma. Biochem. Biophys. Res. Commun. 1993, 196:1010-1016.
39. Zhou Q., He Q., Liang L.-J. Expression of p27, cyclin E and cyclin A in hepatocellular carcinoma and its clinical significance. World J. Gastroenterol. 2003, 9(11):2450-2454.